iBio, Inc.
Pharmaceutical company · New York, United States · Nasdaq: IBIO
iBio, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2008. Its shares trade on Nasdaq under the ticker IBIO. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2026.
iBio at a glance
What does iBio do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $26 million sold (2026).
Frequently asked questions about iBio
Where is iBio headquartered?
iBio, Inc. is headquartered in New York, United States.
What does iBio do?
iBio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is iBio a public company?
Yes. iBio, Inc. trades on Nasdaq under the ticker IBIO.
When was iBio founded?
The earliest incorporation on record for iBio, Inc. is in 2008, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences